📣 Congratulations to Moodmon, the project led by the Polish company Britenet, an InnoStars partner, for being awarded €1 million in funding through EIT Health’s prestigious Flagship Call. With the support of a distinguished European consortium, they are now set to obtain a CE mark, conduct clinical trials, and showcase its real-world healthcare benefits. Additionally, the team is working on creating a legal framework for AI retraining without the need for full recertification.

Curious about how artificial intelligence is transforming psychiatry?

🎙️Tune in to the latest episode of the InnoStars Talks podcast, where Dr Marlena Sokoł-Szawlowska from the Institute of Psychiatry and Neurology in Warsaw, the innovator behind MoodMon, discusses this AI-powered tool for detecting and managing affective disorders such as depression and bipolar disorder.

🎙️ Join us for the third episode of InnoStars Talks, an engaging podcast series presented by EIT Health in partnership with Emerging Europe! Get ready for insightful discussions with health innovators transforming the medical landscape.

🎙️ Join us for the second episode of InnoStars Talks, an engaging podcast series presented by EIT Health in partnership with Emerging Europe! Get ready for insightful discussions with health innovators transforming the medical landscape.

👥 In our first episode, Andrew Wrobel talks with Mate Balazs Kovacs, CEO and co-founder of AIPLabs, about his groundbreaking journey in combating skin diseases with AI-enhanced digital healthcare solutions.

In this episode, Balázs Fürjes invites to a chat with Professor Krzysztof Klincewicz from the Faculty of Management at Warsaw University.

The discussion, hosted by Andrew Wrobel focuses on the importance of collaborative innovation in boosting innovation in the European Union, particularly in countries with moderate or modest innovation scores.

Don't forget to visit our website at eithealth.eu/in-your-region/innostars/ for more information about our new programmes, calls for proposals and applications and events.

In this episode, Balázs Fürjes invites to a chat with Professor Guido Boella, Vice-Rector for Enterprises at the University of Turin. 

The discussion, hosted by Andrew Wrobel focuses on the role of digital innovation hubs in strengthening innovation in the European Union, particularly in countries with moderate or modest innovation scores.

Don't forget to visit our website at eithealth.eu/in-your-region/innostars/ for more information about our new programmes, calls for proposals and applications and events.

When the Covid-19 pandemic hit, health tech stepped up, with what appeared to be 10 years’ worth of innovation occurring in 10 weeks. But, while the pandemic encouraged more partnerships and collaboration in the sector, it has also brought about multiple challenges for start-ups, such as making it more difficult to complete clinical validation through sourcing hardware or delaying the implementation of their go-to-market strategies.

Tamás Békási, RIS Business Creation Manager at the EIT Health InnoStars, spoke with Andrew Wrobel about the current trends in health tech, opportunities and challenges, and offers plenty of advice to future healthcare hackers.

This year a total of 36 teams from all over Europe showcased their budding start-ups in front of a jury of experts and potential investors, competing for a prize pool of 160,000 euros. The flagship programme of the European Institute of Innovation and Technology (EIT), EIT Jumpstarter is a pre-accelerator programme led by EIT Health and involving other EIT Knowledge and Innovation Communities (KICs) with the goal of boosting innovation and entrepreneurship in Central, Eastern and Southern Europe.

In this episode, Balázs Fürjes speaks with Dora Marosvolgyi, EIT Jumpstarter mentor and project manager at EIT Health InnoStars, about the value the programme gives to your entrepreneurs and the innovation it creates.

Don't forget to visit our website at eithealth.eu/in-your-region/innostars/ for more information about our new programmes, calls for proposals and applications and events.

Success in precision medicine depends on accessing high-quality genetic and molecular data that, in conjunction with comprehensive clinical data, can lead to more effective therapies. Although omics data is available on public databases, doctors are not yet able to extract useful value from it owing to its sheer volume and heterogeneity.

While there are solutions to this problem - based on Big Data and Artificial Intelligence - these are mainly designed for specific diseases; this while there are 400 million patients around the globe affected by rare diseases. Kazaam Lab’s solution is an innovative, electronic, passive dosimeter based on a CMOS Floating Gate sensor monolithically implemented on a single chip.

Simona Rombo, an associate professor of computer science at the University of Palermo and one of the founders and the CEO of Kazaam Lab, spoke with Andrew Wrobel about the challenges her start-up has faced and overcome, as well as offering some tips for young researchers developing health solutions.

Spastic hand paralysis is a painfully common problem experienced by patients who have suffered damage to the central nervous system due to a stroke or other causes. These patients are not able to autonomously open their fingers, which significantly impacts quality of life. There are about 20 million people suffering from hand spasticity worldwide, out of which 1.3 million people live in Europe.

Phoenix Orthosis uses an innovative approach to substitute the fingers’ ability to open, while intentionally remaining as discreet as possible. Thus, the paralysed hand can be reintegrated into everyday life which is the most effective route to rehabilitation.

Robert Ackermann, CCO at Phoenix Orthosis, spoke with Andrew Wrobel about the solution, its implementation on the German market and the impact the Covid-19 pandemic has had on the development of the product.